Safety and Efficacy of Ledipasvir/Sofosbuvir in a Genotype 1 HCV Infected Chinese Population: Results from a Phase 3, Clinical Trial

被引:0
作者
Wei, Lai [1 ]
Xie, Qing [2 ]
Hou, Jinlin [3 ]
Tang, Hong [4 ]
Ning, Qin [5 ]
Cheng, Jun [6 ]
Nan, Yuemin [7 ]
Zhang, Lunli [8 ]
Li, Jun [9 ]
Jiang, Jianning [10 ]
McNabb, Brian L. [11 ]
Zhang, Fangqiu [12 ]
Camus, Gregory [13 ]
Mo, Hongmei [13 ]
McNally, John [11 ]
Brainard, Diana M. [11 ]
Subramanian, Mani [11 ]
Gong, Guozhong [14 ]
Mou, Zhuangbo [15 ]
Wu, Shanming [16 ]
Wang, Qui-Qiang [17 ]
Hu, Peng [18 ]
Gao, Yanhang [19 ]
Jia, Jidong [20 ]
Duan, Zhongping [21 ]
机构
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China
[4] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China
[5] Huanzhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
[6] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China
[7] Hebei Med Univ, Hosp 3, Shijiazhuang, Hebei, Peoples R China
[8] Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China
[9] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China
[10] Guangxi Med Univ, Affiliated Hosp 1, Guangxi, Peoples R China
[11] Gilead Sci Inc, Clin Res, 353 Lakeside Dr, Foster City, CA 94404 USA
[12] Gilead Sci Inc, Biostat, 353 Lakeside Dr, Foster City, CA 94404 USA
[13] Gilead Sci Inc, Virol, 353 Lakeside Dr, Foster City, CA 94404 USA
[14] Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China
[15] Jinan Infect Dis Hosp, Jinan, Shandong, Peoples R China
[16] Clin Ctr Shanghai Publ Hlth, Shanghai, Peoples R China
[17] Peking Univ, Hosp 1, Beijing, Peoples R China
[18] Chongqing Med Univ, Affiliated Hosp 2, Chongqing, Peoples R China
[19] Jilin Univ, Hosp 1, Changchun, Jilin, Peoples R China
[20] Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China
[21] Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1191
引用
收藏
页码:642A / 642A
页数:1
相关论文
共 50 条
[31]   Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study [J].
Lai Wei ;
Qing Xie ;
Jin Lin Hou ;
Hong Tang ;
Qin Ning ;
Jun Cheng ;
Yuemin Nan ;
Lunli Zhang ;
Jun Li ;
Jianning Jiang ;
Brian McNabb ;
Fangqiu Zhang ;
Gregory Camus ;
Hongmei Mo ;
Anu Osinusi ;
Diana M. Brainard ;
Guozhong Gong ;
Zhuangbo Mou ;
Shanming Wu ;
Guiqiang Wang ;
Peng Hu ;
Yanhang Gao ;
Jidong Jia ;
Zhongping Duan .
Hepatology International, 2018, 12 :126-132
[32]   Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study [J].
Wei, Lai ;
Xie, Qing ;
Hou, Jin Lin ;
Tang, Hong ;
Ning, Qin ;
Cheng, Jun ;
Nan, Yuemin ;
Zhang, Lunli ;
Li, Jun ;
Jiang, Jianning ;
McNabb, Brian ;
Zhang, Fangqiu ;
Camus, Gregory ;
Mo, Hongmei ;
Osinusi, Anu ;
Brainard, Diana M. ;
Gong, Guozhong ;
Mou, Zhuangbo ;
Wu, Shanming ;
Wang, Guiqiang ;
Hu, Peng ;
Gao, Yanhang ;
Jia, Jidong ;
Duan, Zhongping .
HEPATOLOGY INTERNATIONAL, 2018, 12 (02) :126-132
[33]   Safety and Efficacy of 8-weeks Ledipasvir/Sofosbuvir Combination in Chronic Hepatitis C Genotype 4-Infected Patients [J].
Babatin, Mohamed ;
Alghamdi, Abdullah S. ;
Assiri, Abdullah ;
Aleladi, Haziz ;
Shoja, Hamad ;
Mogharbel, Mohaammed ;
Alsahafi, Ashwaq ;
Mahalawi, Wadad ;
Sanai, Faisl .
HEPATOLOGY, 2017, 66 :821A-821A
[34]   Efficacy and safety of sofosbuvir and ledipasvir in Japanese patients aged 75 years or over with hepatitis C genotype 1 [J].
Yoshinori Ozono ;
Kenji Nagata ;
Satoru Hasuike ;
Hisayoshi Iwakiri ;
Kenichi Nakamura ;
Mai Tsuchimochi ;
Yuri Yamada ;
Yuka Takaishi ;
Mitsue Sueta ;
Tadashi Miike ;
Yoshihiro Tahara ;
Shojiro Yamamoto ;
Kotaro Shide ;
Tomonori Hidaka ;
Yoko Kubuki ;
Kazunori Kusumoto ;
Toshimasa Ochiai ;
Junya Kato ;
Naoto Komada ;
Shuichi Hirono ;
Kazuo Kuroki ;
Masafumi Shigehira ;
Kazuya Shimoda .
World Journal of Hepatology, 2017, (36) :1340-1345
[35]   Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis [J].
He, Qiu-Feng ;
Zhang, Qiong-Fang ;
Zhang, Da-Zhi .
DIGESTIVE DISEASES AND SCIENCES, 2016, 61 (11) :3108-3117
[36]   Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis [J].
Qiu-Feng He ;
Qiong-Fang Zhang ;
Da-Zhi Zhang .
Digestive Diseases and Sciences, 2016, 61 :3108-3117
[37]   Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Subjects Aged 65 Years or Older [J].
Saab, Sammy ;
Park, Sarah H. ;
Mizokami, Masashi ;
Omata, Masao ;
Mangia, Alessandra ;
Eggleton, Ed ;
Zhu, Yanni ;
Knox, Steven J. ;
Pang, Phil ;
Subramanian, Mani ;
Kowdley, Kris ;
Afdhal, Nezam H. .
HEPATOLOGY, 2016, 63 (04) :1112-1119
[38]   Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in HCV genotype IV infected patients [J].
Wang, Bin-Qiao ;
Wang, Yong-Lin ;
Shi, Ke-Qing .
LIVER INTERNATIONAL, 2017, 37 (05) :765-765
[39]   EFFICACY AND SAFETY OF SOFOSBUVIR BASED TREATMENTS IN GENOTYPE 3 AND 6 HCV PATIENTS IN SOUTH CHINA [J].
Jiang, Mengfeng ;
Su, Minghua ;
Long, Shiyu ;
Li, Linman ;
Liang, Dandan ;
Huang, Jinni .
HEPATOLOGY, 2022, 76 :S413-S414
[40]   Safety and Efficacy of Velpatasvir and Sofosbuvir-based Regimens for the Treatment of HCV Genotype 1-6: Results of the HCV-TARGET Study [J].
Landis, Charles S. ;
Sulkowski, Mark S. ;
Reau, Nancy ;
Lutchman, Glen A. ;
Vainorius, Monika ;
Welzel, Tania M. ;
Zeuzem, Stefan ;
Khalili, Mandana ;
Nelson, David R. ;
Lok, Anna S. ;
Fried, Michael W. ;
Terrault, Norah .
HEPATOLOGY, 2017, 66 :587A-587A